Tag: Prescription Drugs
FDA Authorizes Use of Monoclonal Antibody Treatment for COVID-19
IV infusion of casirivimab and imdevimab authorized for treatment of mild-to-moderate COVID-19
FDA Issues EUA to Baricitinib Plus Remdesivir for COVID-19
Emergency use authorization applies to hospitalized patients requiring supplemental oxygen, mechanical ventilation, ECMO
Lorlatinib Superior to Crizotinib for ALK-Positive NSCLC
Interim analysis shows risk for disease progression or death lower for first-line therapy with lorlatinib versus crizotinib
Disproportionality Signal Found for Suicidality in Finasteride Users
Younger patients and those with alopecia have significant disproportionality signals for increased suicidality
AHA: Polypill, With or Without Aspirin, Reduces Cardiovascular Events
Significant reductions seen in primary outcome for use of polypill and polypill plus aspirin combination
Triplet Therapy Slows Refractory Multiple Myeloma
Progression-free survival longer with once-weekly selinexor-containing regimen versus standard bortezomib and dexamethasone
Fluvoxamine Linked to Reduction in Clinical Deterioration in COVID-19
Findings seen among adult outpatients with SARS-CoV-2 with oxygen saturation of 92 percent or greater
Nebulized Interferon Beta-1a Promising for COVID-19
Adults hospitalized for COVID-19 receiving SNG001 versus placebo more likely to show clinical improvement
ACR Previews New Pharmacotherapy Guidelines for RA
The 2020 Guideline for the Management of Rheumatoid Arthritis updates guidance on drug treatments
ACR: Warfarin Tied to Increased Risk for Knee, Hip Replacement in OA
Among adults with atrial fibrillation, warfarin use linked to increased odds of knee, hip replacement versus direct oral anticoagulants
